BioStock: Saniona strengthened its cash position and advanced through partnership
Saniona’s key milestone in 2024 was securing an exclusive worldwide licensing agreement with Acadia Pharmaceuticals worth up to USD 610…
18,177$
0,12%
Echtzeit-Aktienkurs Acadia Pharmaceuticals Inc.
Bid:
Ask:
Nachrichten zur Acadia Pharmaceuticals Inc. Aktie
Acadia Pharmaceuticals (ACAD) Q4 Earnings Lag Estimates
Acadia (ACAD) delivered earnings and revenue surprises of -10.53% and 1.79%, respectively, for the quarter ended December 2024. Do the…
BioStock: Saniona’s CEO responds to investors’ questions
Saniona’s collaboration with Acadia Pharmaceuticals, signed in November, marked a significant milestone for the company. With a total potential value…
Acadia Pharmaceuticals: DAYBUE steht vor Alleinstellung in der EU, den USA und Kanada
Die Aktie von Acadia Pharmaceuticals befindet sich bereits seit langer Zeit auf der Watchlist für unser Frühwarnsystem. Seit ich diese…
Saniona’s CEO to BioStock: “The deal with Acadia is significant”
Saniona has announced a partnership with Acadia Pharmaceuticals to develop and commercialize SAN711. The total potential deal size is USD…
NRx Pharmaceuticals, Inc. (NRXP) Q3 2024 Earnings Call Transcript
…
ACADIA Pharmaceuticals Inc. (ACAD) Q3 2024 Earnings Conference Call Transcript
…
ACADIA Pharmaceuticals Inc. 2024 Q3 - Results - Earnings Call Presentation
…
Acadia Pharmaceuticals: Nuplazid Performs In Q2 While Daybue Disappoints Again
…
NRx Pharmaceuticals, Inc. (NRXP) Q2 2024 Earnings Call Transcript
…
ACADIA Pharmaceuticals Inc. 2024 Q2 - Results - Earnings Call Presentation
…
Acadia Pharmaceuticals: Back In The Buy Zone
…
Acadia Pharmaceuticals: Bullish On Nuplazid And Daybue Driven Growth In CNS Treatments
…
Adial Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
GLEN ALLEN, Va., May 15, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”),…
NRx Pharmaceuticals, Inc. (NRXP) Q1 2024 Earnings Call Transcript
…
ACADIA Pharmaceuticals Inc. (ACAD) Q1 2024 Earnings Call Transcript
…
ACADIA Pharmaceuticals Inc. 2024 Q1 - Results - Earnings Call Presentation
…
Biotech Stock Roundup: AMLX, ACAD Down on Study Data, MRNA, RGLS Gain on Updates & More
Amylyx Pharmaceuticals (AMLX) and Acadia Pharmaceuticals (ACAD) plunged on failure of studies.…
Acadia Pharmaceuticals: Post Pimavanserin Study Setback Selloff May Continue
…
Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds
CHARLOTTESVILLE, Va., March 01, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a…
Acadia Pharmaceuticals: New Daybue Drug Already Showing Signs Of Slowing
…
Acadia Pharmaceuticals: Daybue Growth Concerns, Important Data Readout Coming
…
ACADIA Pharmaceuticals Inc. (ACAD) Q4 2023 Earnings Call Transcript
…
ACADIA Pharmaceuticals Inc. 2023 Q4 - Results - Earnings Call Presentation
…